Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Terpstra, W.E.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(1)
+
-
Creation Date
2022
(2)
+
-
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(3)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(3)
+
-
Author
Terpstra, W.E.
(4)
+
-
Tick, L.W.
(4)
+
-
Gelder, M. van
(3)
+
-
Boer, F. de
(2)
+
-
Deeren, D.
(2)
+
-
Dobber, J.A.
(2)
+
-
Dompeling, E.C.
(2)
+
-
Dubois, J.
(2)
+
-
Evers, L.M.
(2)
+
-
Hoogendoorn, M.
(2)
+
-
Houtenbos, I.
(2)
+
-
Idink, C.A.M.
(2)
+
-
Issa, D.E.
(2)
+
-
Kater, A.P.
(2)
+
-
Kersting, S.
(2)
+
-
Kevie-Kersemaekers, A.M.F. van der
(2)
+
-
Klift, M. van der
(2)
+
-
Koene, H.R.
(2)
+
-
Levenga, H.
(2)
+
-
Levin, M.D.
(2)
+
-
Nasserinejad, K.
(2)
+
-
Posthuma, E.F.M.
(2)
+
-
Schreurs, J.
(2)
+
-
Spek, E. van der
(2)
+
-
Straaten, H.M. van der
(2)
+
-
Tonino, S.H.
(2)
+
-
Veelken, H.
(2)
+
-
Velders, G.A.
(2)
+
-
Visser, H.P.J.
(2)
+
-
Zaanen, H.C.T. van
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK)
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL